Carilex Medical (ROCO:7726) Total Assets: NT$534.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7726 Carilex Medical Inc ROCO:7726
35 GF Score
Price NT$31.95
! 5 Warning Signs
View Full Analysis

What is Carilex Medical Total Assets?

Carilex Medical ROCO:7726 35 Total Assets is NT$534.0 Mil as of Dec. 2025. GuruFocus rates ROCO:7726 with a GF Score™ of 35/100. The stock has 5 warning signs investors should review.

Carilex Medical's Total Assets for the quarter that ended in Dec. 2025 was NT$534.0 Mil.

During the past 12 months, Carilex Medical's average Total Assets Growth Rate was -4.00% per year. During the past 3 years, the average Total Assets Growth Rate was 2.80% per year. During the past 5 years, the average Total Assets Growth Rate was 5.30% per year.

During the past 6 years, Carilex Medical's highest 3-Year average Total Assets Growth Rate was 14.10%. The lowest was 2.80%. And the median was 5.10%.

Total Assets is connected with ROA %. Carilex Medical's annualized ROA % for the quarter that ended in Dec. 2025 was -7.51%. Total Assets is also linked to Revenue through Asset Turnover. Carilex Medical's Asset Turnover for the quarter that ended in Dec. 2025 was 0.38.


Carilex Medical  (ROCO:7726) Total Assets Explanation

Total Assets is connected with ROA %.

Carilex Medical's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-36.734/( (444.243+533.955)/ 2 )
=-36.734/489.099
=-7.51 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Carilex Medical's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=186.307/( (444.243+533.955)/ 2 )
=186.307/489.099
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Carilex Medical Total Assets Related Terms


Carilex Medical Total Assets Historical Data

* Premium members only.

The historical data trend for Carilex Medical's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carilex Medical Total Assets Chart

Carilex Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 416.61 414.73 543.44 459.63 533.96

Carilex Medical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 543.44 513.56 459.63 444.24 533.96
ROCO:7726
35GF Score
Carilex Medical Inc ROCO:7726
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carilex Medical Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Carilex Medical's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=290.931+243.024
=534.0

Carilex Medical's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=290.931+243.024
=534.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of NT$534.0 Mil mean?
Carilex Medical (ROCO:7726) has a Total Assets of NT$534.0 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Carilex Medical and its competitors.
Is Carilex Medical's Total Assets too high?
Carilex Medical's current Total Assets is NT$534.0 Mil. Overall, Carilex Medical has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Carilex Medical's Total Assets compare to ABT and SYK?
Carilex Medical's Total Assets of NT$534.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Carilex Medical and its competitors. Carilex Medical's current Total Assets is NT$534.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carilex Medical stock overvalued right now?
Carilex Medical (ROCO:7726) has a current Total Assets of NT$534.0 Mil. The current Total Assets is NT$534.0 Mil. Carilex Medical's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Carilex Medical (ROCO:7726), the current Total Assets is NT$534.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carilex Medical Business Description

Address No.77, Keji 1st Road, Guishan District, Taoyuan, TWN, 33383
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.
35GF Score

Get the complete analysis for ROCO:7726

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.95
Price